Abstract
Paediatric practice recommendations on the use of tacrolimus following kidney transplantation are largely based on the experience from adult solid organ recipients. It has been reported that adequate tacrolimus exposure in adults can impact patient outcomes. As shown in the SYMPHONY trial, adult de novo kidney transplant patients with a target tacrolimus pre-dose concentration (TAC C0 ) of 3-7ng/ml had a higher glomerular filtration rate and a lower incidence of acute rejection oneyear following transplantation compared to those treated with cyclosporine A or sirolimus.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Transplant international : official journal of the European Society for Organ Transplantation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
